SMARCD2 and acute myeloid leukemia: We next aimed to define the impact of the SMARCD2 SWIFT domain mutation on the targeting and accessibility generation of mSWI/SNF complexes in human AML cells using CUT&RUN and ATAC-seq, respectively.